4-(Difluoromethyl)benzonitrile | CAS:55805-10-2

We serve 4-(Difluoromethyl)benzonitrile CAS:55805-10-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-(Difluoromethyl)benzonitrile

Chemical Name:4-(Difluoromethyl)benzonitrile
CAS.NO:55805-10-2
Synonyms:4-(Difluoromethyl)benzonitrile
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 224.3±35.0 °C at 760 mmHg
Molecular Formula C8H5F2NO
Molecular Weight 153.129
Flash Point 89.4±25.9 °C
Vapour Pressure 0.1±0.4 mmHg at 25°C
Index of Refraction 1.480
 
Specification:
Appearance:Off-white powder
Assay:≥98.0%
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 4-(Difluoromethyl)benzonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(Difluoromethyl)benzonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(Difluoromethyl)benzonitrile Use and application,4-(Difluoromethyl)benzonitrile technical grade,usp/ep/jp grade.


Related News: INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.11α-Hydroxy Canrenone manufacturer In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.4-Dibenzothienylboronic acid supplier In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.Pentyl chloroformate vendor In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.Judging from the geographical distribution of enterprises, the largest distribution of API companies is Jiangsu and Zhejiang, with more than 300 enterprises; followed by Shandong, Sichuan and Hubei.